(Q77877415)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932152%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Evolution of HIV disease in the third millennium: clinical and related economic issues (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932152%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Roberto Manfredi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932152%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932152%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Antimicrobial Agents

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932152%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932152%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932152%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

251-253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932152%20AND%20SRC:MED&resulttype=core&format=json

The cost of HIV treatment and care. A global review

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

Progress in HIV therapeutics and the challenges of adherence to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

Providing antiretroviral therapy for HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

The cost effectiveness of combination antiretroviral therapy for HIV disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

Cost effectiveness of combination HIV therapy: 3 years later

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

Modeling the Long-Term Outcomes and Costs of HIV Antiretroviral Therapy Using HIV RNA Levels: Application to a Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900494-0

7 January 2021

10.1016/S0924-8579(01)00494-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11932152%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference